Physician profile
Mark K Palit
NPI 1568404788
$19,322.64
in general payments reported to CMS, 2019-2025
23 companies · $4,315 in 2025
The $4,315 reported for 2025 was more than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,693 · 2020: $1,301 · 2021: $4,823 · 2022: $2,820 · 2023: $2,791 · 2024: $580 · 2025: $4,315.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,832 · Food and Beverage: $3,807 · Education: $46.78.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,832.13 |
| Food and Beverage | $3,807.38 |
| Education | $46.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $6,246.95 | 2019-2025 | Mini-Open Latarjet, Microraptor, Q-Fix |
| Zimmer Biomet Holdings, INC. | $4,791.77 | 2020-2025 | Oxford, Persona, Rosa |
| Arthrex, INC. | $2,059.26 | 2021-2023 | Shoulder Implants |
| Si-Bone, INC. | $1,744.83 | 2019-2023 | |
| Wardlow Enterprises | $1,675.13 | 2019-2023 | |
| Aesculap Implant Systems, LLC | $974.85 | 2021 | |
| Stryker Corporation | $286.93 | 2019-2025 | Inspace, Alphavent, Cobra |
| Prism Medical | $263.64 | 2024-2025 | |
| Abbott Laboratories | $211.85 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $167.18 | 2023-2024 | Exparel, Iovera, Zilretta |
| Heron Therapeutics, INC. | $137.69 | 2021-2024 | Zynrelef |
| Inspire Medical Systems, INC. | $127.71 | 2025 | Inspire |
| Encore Medical, LP | $127.64 | 2025 | Djo Surgical |
| Intrinsic Therapeutics | $119.09 | 2023 | Barricaid Acd (Annular Closure Device) |
| Orthalign INC | $118.58 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rhythm Pharmaceuticals, INC. | $75.98 | 2021 | |
| Maxx Orthopedics, INC. | $74.70 | 2019 | |
| Depuy Synthes Sales INC. | $37.67 | 2025 | Monovisc |
| Surgalign Spine Technologies, INC. | $19.50 | 2020 | |
| Medtronic USA, INC. | $17.91 | 2019 | |
| Novo Nordisk INC | $17.27 | 2023 | Wegovy |
| Supernus Pharmaceuticals, INC. | $14.83 | 2022 | |
| Heraeus Medical, LLC. | $11.68 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Palit listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.